Filter
211
Text search:
external
quality
assessment
(EQA)
Featured
Recommendations
36
New Publications
96
Language
Document type
No document type
126
Studies & Reports
30
Guidelines
28
Manuals
11
Strategic & Response Plan
11
Situation Updates
2
Fact sheets
2
Online Courses
1
Countries / Regions
India
23
Ethiopia
11
Nepal
9
Kenya
9
Tanzania
8
Nigeria
7
Uganda
7
Malawi
6
East and Southern Africa
6
Ghana
5
Western and Central Europe
5
Africa
5
Sierra Leone
4
Philippines
4
West and Central Africa
4
Global
4
Liberia
3
Cambodia
3
Rwanda
3
Bangladesh
3
Namibia
3
Lesotho
3
South–East Asia Region
3
Latin America and the Carribbean
3
Asia
3
Eastern Europe
3
Pakistan
2
Zambia
2
South Africa
2
Brazil
2
Myanmar / Burma
2
Middle East and North Africa
2
Western Pacific Region
2
Senegal
1
Zimbabwe
1
Jordan
1
Afghanistan
1
Mozambique
1
Botswana
1
Libya
1
Angola
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
Laos
1
Tajikistan
1
Russia
1
Kazakhstan
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
124
Pharmacy & Technologies
14
Clinical Guidelines
10
Key Resources
6
Public Health
3
Capacity Building
1
Women & Child Health
1
Toolboxes
TB
40
AMR
21
COVID-19
20
NTDs
13
HIV
12
Rapid Response
4
Malaria
4
Pharmacy
3
2.0 Rapid Response
3
Cholera
2
Polio
1
Zika
1
NCDs
1
Epidemiology, Control, and Financing
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio
...
2nd edition
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
The present National action plan on antimicrobial resistance (AMR) with component of antimicrobial consumption (AMC) covering both human and agriculture sectors was developed based on the World Health Organization's (WHO) Global plan on AMR dated 2015. With the purpose to develop this plan, in May 2
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
National Essential Diagnostic List
recommended
Policy and Manual
2nd edition